Literature DB >> 14573599

The crystal structure of gankyrin, an oncoprotein found in complexes with cyclin-dependent kinase 4, a 19 S proteasomal ATPase regulator, and the tumor suppressors Rb and p53.

Szymon Krzywda1, Andrzej M Brzozowski, Hiroaki Higashitsuji, Jun Fujita, Rebecca Welchman, Simon Dawson, R John Mayer, Anthony J Wilkinson.   

Abstract

Gankyrin is a 25-kDa hepatocellular carcinoma-associated protein that mediates protein-protein interactions in cell cycle control and protein degradation. It has been reported to form complexes with cyclin-dependent kinase 4, retinoblastoma protein, the S6b ATPase subunit of the 19 S regulator of the 26 S proteasome, and Mdm2, an E3 ubiquitin ligase involved in p53 degradation. It is the first protein described to bind both to the 26 S proteasome and to proteins in other complexes containing cyclin-dependent kinase(s) and p53 ubiquitylating activities, thus providing a mechanism for delivering cell cycle regulating machinery and ubiquitylated substrates to the proteasome for degradation. Gankyrin contains a 33-residue motif known as the ankyrin repeat that occurs five and a half to six times in the sequence. As a step toward understanding gankyrin interactions with its protein partners we have determined its three-dimensional crystal structure to 2.0-A resolution. It reveals that the entire 226-residue gankyrin polypeptide folds into seven ankyrin repeat elements. The ankyrin repeats, consisting of an antiparallel beta-hairpin followed by a perpendicularly oriented helix-loop-helix, pack side-by-side, creating an extended curved structure with a groove running across the long concave surface. Comparison with the structures of other ankyrin repeat proteins suggests that interactions with partner proteins are mediated by residues situated on this concave surface.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14573599     DOI: 10.1074/jbc.M310265200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  26 in total

1.  Mechanical unfolding of an ankyrin repeat protein.

Authors:  David Serquera; Whasil Lee; Giovanni Settanni; Piotr E Marszalek; Emanuele Paci; Laura S Itzhaki
Journal:  Biophys J       Date:  2010-04-07       Impact factor: 4.033

Review 2.  Small-Molecule Inhibitors of the Proteasome's Regulatory Particle.

Authors:  Christine S Muli; Wenzhi Tian; Darci J Trader
Journal:  Chembiochem       Date:  2019-05-24       Impact factor: 3.164

3.  Gankyrin plays an essential role in Ras-induced tumorigenesis through regulation of the RhoA/ROCK pathway in mammalian cells.

Authors:  Jiang-Hong Man; Bing Liang; Yue-Xi Gu; Tao Zhou; Ai-Ling Li; Tao Li; Bao-Feng Jin; Bing Bai; Hai-Ying Zhang; Wei-Na Zhang; Wei-Hua Li; Wei-Li Gong; Hui-Yan Li; Xue-Min Zhang
Journal:  J Clin Invest       Date:  2010-07-12       Impact factor: 14.808

Review 4.  Gankyrin as a potential target for tumor therapy: evidence and perspectives.

Authors:  Haixai Li; Junyan Zhang; Cheng Zhen; Baojun Yang; Limin Feng
Journal:  Am J Transl Res       Date:  2018-07-15       Impact factor: 4.060

Review 5.  Inhibition of apoptosis by oncogenic hepatitis B virus X protein: Implications for the treatment of hepatocellular carcinoma.

Authors:  Chuck C K Chao
Journal:  World J Hepatol       Date:  2016-09-08

6.  Structural basis for recognition of 2',5'-linked oligoadenylates by human ribonuclease L.

Authors:  Nobutada Tanaka; Masayuki Nakanishi; Yoshio Kusakabe; Yoshikuni Goto; Yukio Kitade; Kazuo T Nakamura
Journal:  EMBO J       Date:  2004-09-23       Impact factor: 11.598

7.  In vivo binding and retention of CD4-specific DARPin 57.2 in macaques.

Authors:  Pavel Pugach; Anders Krarup; Agegnehu Gettie; Marcelo Kuroda; James Blanchard; Michael Piatak; Jeffrey D Lifson; Alexandra Trkola; Melissa Robbiani
Journal:  PLoS One       Date:  2010-08-27       Impact factor: 3.240

8.  Functional characterization of human oncoprotein gankyrin in Zebrafish.

Authors:  So Yeon Kim; Wonhee Hur; Jung Eun Choi; Daniel Kim; Jin Sang Wang; Hye Yeon Yoon; Lian Shu Piao; Seung Kew Yoon
Journal:  Exp Mol Med       Date:  2009-01-31       Impact factor: 8.718

9.  The study of pH-dependent stability shows that the TPLH-mediated hydrogen-bonding network is important for the conformation and stability of human gankyrin.

Authors:  Chunhua Yuan; Yi Guo; Lu Zhu; Wei Guo; Anjali Mahajan; Christopher M Weghorst; Junan Li
Journal:  Biochemistry       Date:  2013-07-08       Impact factor: 3.162

10.  Disruption of G1-phase phospholipid turnover by inhibition of Ca2+-independent phospholipase A2 induces a p53-dependent cell-cycle arrest in G1 phase.

Authors:  Xu Hannah Zhang; Chunying Zhao; Konstantin Seleznev; Keying Song; James J Manfredi; Zhongmin Alex Ma
Journal:  J Cell Sci       Date:  2006-02-21       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.